Overview

Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
A multicenter study to evaluate the effectiveness and safety of multiple dosage regimens of an investigational drug for the treatment of constipation due to prescription pain medication in subjects with cancer pain. The study will require five visits over a five-week period.
Phase:
Phase 2
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Collaborator:
GlaxoSmithKline
Treatments:
Alvimopan
Analgesics